These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2961426)

  • 1. The cardiovascular amplifiers in human primary hypertension and their role in a strategy for detecting the underlying causes.
    Korner PI; Jennings GL; Esler MD; Anderson WP; Bobik A; Adams M; Angus JA
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1730-8. PubMed ID: 2961426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of cardiovascular hypertrophy in the development and maintenance of hypertension.
    Korner PI; Bobik A; Jennings GL; Angus JA; Anderson WP
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S25-32. PubMed ID: 1715480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are cardiac and vascular "amplifiers" both necessary for the development of hypertension?
    Korner PI; Bobik A; Angus JJ
    Kidney Int Suppl; 1992 Jun; 37():S38-44. PubMed ID: 1385838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplifier function of resistance vessels and the left ventricle in hypertension.
    Korner PI; Angus JA; Bobik A; Jennings GL
    J Hypertens Suppl; 1991 Dec; 9(2):S31-40; discussion S40-1. PubMed ID: 1838766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antihypertensive therapy on the cardiovascular amplifiers.
    Korner PI; Adams MA; Jennings GL; Bobik A
    Clin Exp Pharmacol Physiol; 1988 Mar; 15(3):191-7. PubMed ID: 2978739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach to the identification of pathogenetic factors and to therapy in human primary hypertension.
    Korner PI; Jennings GL; Esler MD; Broughton A
    J Clin Hypertens; 1987 Jun; 3(2):187-96. PubMed ID: 2956375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cardiac and vascular amplifiers in the maintenance of hypertension and the effect of reversal of cardiovascular hypertrophy.
    Korner PI; Jennings GL; Esler MD; Broughton A
    Clin Exp Pharmacol Physiol; 1985; 12(3):205-9. PubMed ID: 3161672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role for the cardiovascular amplifiers in human primary hypertension.
    Jennings G; Korner PI; Sudhir K; Esler M; Angus JA; Laufer E
    Clin Exp Pharmacol Physiol; 1991 Jan; 18(1):37-41. PubMed ID: 2032389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular hypertrophy and hypertension: causes and consequences.
    Korner PI
    Blood Press Suppl; 1995; 2():6-16. PubMed ID: 7582077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and biochemical analyses of isolated rat hearts in renal and reversed renal hypertension.
    Friberg P; Rupp H; Nordlander M
    Acta Physiol Scand; 1989 Feb; 135(2):123-32. PubMed ID: 2522266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of human primary hypertension: a new approach to the identification of causal factors and to therapy.
    Korner PI; Jennings GL; Esler MD
    J Hypertens Suppl; 1986 Oct; 4(3):S149-53. PubMed ID: 2878068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of left ventricular hypertrophy, afterload, and contractility to left ventricular performance in Goldblatt hypertension.
    de Simone G; Devereux RB; Volpe M; Camargo MJ; Wallerson DC; Laragh JH
    Am J Hypertens; 1992 May; 5(5 Pt 1):292-301. PubMed ID: 1533770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary blood flow during the development and regression of left ventricular hypertrophy in renovascular hypertensive rats.
    Wicker P; Tarazi RC; Kobayashi K
    Am J Cardiol; 1983 Jun; 51(10):1744-9. PubMed ID: 6222644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-glomerular structural changes in the renal vasculature in hypertension.
    Anderson WP; Kett MM; Evans RG; Alcorn D
    Blood Press Suppl; 1995; 2():74-80. PubMed ID: 7582080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of left ventricular hypertrophy in two-kidney, one clip Goldblatt hypertension.
    Kuwajima I; Kardon MB; Pegram BL; Sesoko S; Frohlich ED
    Hypertension; 1982; 4(3 Pt 2):113-8. PubMed ID: 6461595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular response and red cell membrane sodium transport in hypertensive cardiac hypertrophy.
    Saito T; Kai N; Yamamoto K; Iwata J; Deguchi F; Inagaki Y
    J Hum Hypertens; 1993 Oct; 7(5):485-9. PubMed ID: 8263890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympatho-adrenal mechanisms regulating cardiovascular hypertrophy in primary hypertension: a role for rilmenidine?
    Bobik A; Dilley R; Kanellakis P
    J Hypertens Suppl; 1998 Aug; 16(3):S51-4. PubMed ID: 9747911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling of the rat right and left ventricles in experimental hypertension.
    Brilla CG; Pick R; Tan LB; Janicki JS; Weber KT
    Circ Res; 1990 Dec; 67(6):1355-64. PubMed ID: 1700933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.